Concepedia

Avital Beig

AB

Statistics

Publications

27

Citations

1.8K

H-Index

20

Active since

2011

Affiliations

Ben-Gurion University of the Negev(Current)

AbbVie (United States)

University of Michigan

BioSurfaces (United States)

Abbott Fund

Avital Beig is an author at Ben-Gurion University of the Negev specializing in pharmacy, pharmaceutics, and bioavailability.

ORCID

Publications per year

2011–2023

27

Publications

27

A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability

Jonathan M. Miller, Avital Beig, Robert A. Carr et al. · Molecular Pharmaceutics · 2012 · 255 citations

, , +16

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Jonathan M. Miller, Avital Beig, Brian J. Krieg et al. · Molecular Pharmaceutics · 2011 · 204 citations

, , +17

Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations

Avital Beig, Riad Agbaria, Arik Dahan · PLoS ONE · 2013 · 131 citations · Full text

, , +16

The Solubility–Permeability Interplay When Using Cosolvents for Solubilization: Revising the Way We Use Solubility-Enabling Formulations

Jonathan M. Miller, Avital Beig, Robert Carr et al. · Molecular Pharmaceutics · 2012 · 131 citations

, , +17

Accounting for the solubility–permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption

Avital Beig, Jonathan M. Miller, Arik Dahan · European Journal of Pharmaceutics and Biopharmaceutics · 2012 · 103 citations

, , +17

1–5 of 27